Background
The Model for End-Stage Liver Disease (MELD) score, which estimates mortality within 90 days, determines priority for liver transplantation (LT). However, longer-term outcomes on the waitlist for patients who are initially listed with low MELD scores are not well-characterized.
Methods
All adults listed for primary liver transplantation at a single, high-volume center from 2005-12 with an initial laboratory MELD 22 or lower were evaluated. Excluded were those listed with MELD exception points, who underwent living donor LT (LDLT) or transplant at another center, or who were removed from the waitlist for non-medical reasons. Outcomes and causes of death were identified by UNOS, the National Death Index, and an electronic medical record review. Multivariable competing risk analysis evaluated predictors of death compared to deceased donor LT (DDLT).
Results
893 patients were listed from 2005-12. By the end of follow-up, 27% had undergone DDLT, and 31% were removed from the waitlist for death or clinical deterioration. In competing risks assessment, only MELD 6-9, older age, lower serum albumin, lower BMI, and diabetes conferred increased risk of waitlist dropout compared to DDLT. Listing for SLK was protective against waitlist dropout. 275 patients died or were delisted for being too sick; 87% of the identifiable causes of death were directly related to end-stage liver disease or hepatocellular carcinoma.
Conclusion
Patients with low listing MELD scores remain at significant risk for death due to liver-related causes and may benefit from early access to transplantation, such as LDLT or acceptance of high-risk donor livers. Predictors of death compared to transplantation may allow for early identification of patients who are at risk for waitlist mortality.